DeepMed Research

UNIVERSITY OF SYDNEY

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Established: 1850-01-01

Employees: -

Market Cap: -

Website: https://www.sydney.edu.au/

Clinical Trials

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

Phase 2

Completed

Conditions: Herpes Zoster

Interventions: Biological: Zostavax

First Posted Date: 2012-04-06

Last Posted Date: 2018-05-11

Lead Sponsor: University of Sydney

Target Recruit Count: 8

Registration Number: NCT01573182

Locations: 🇦🇺
Westmead Hospital, Sydney, New South Wales, Australia

The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study

Phase 1

Completed

Conditions: Diabetes Mellitus, Type 2
Insulin Resistance

Interventions: Dietary Supplement: Zinc supplements
Dietary Supplement: Omega 3 supplements
Dietary Supplement: Placebo supplements

First Posted Date: 2012-01-09

Last Posted Date: 2012-01-09

Lead Sponsor: University of Sydney

Target Recruit Count: 48

Registration Number: NCT01505803

Locations: 🇦🇺
University of Sydney, Sydney, New South Wales, Australia

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

Phase 3

Recruiting

Conditions: Type 1 Diabetes Mellitus
Diabetic Retinopathy
Diabetic Nephropathies

Interventions: Drug: Fenofibrate
Drug: Inert lactose placebo

First Posted Date: 2011-03-22

Last Posted Date: 2025-04-04

Lead Sponsor: University of Sydney

Target Recruit Count: 450

Registration Number: NCT01320345

Locations: 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺
Southern Adelaide Diabetes and Endocrine Services, Oaklands Park, South Australia, Australia
🇦🇺
University Hospital Geelong, Geelong, Victoria, Australia

and more 20 locations

Patient INformation About Options for Treatment - PINOT

Completed

Conditions: Chronic Kidney Disease

First Posted Date: 2011-02-17

Last Posted Date: 2011-02-17

Lead Sponsor: University of Sydney

Target Recruit Count: 721

Registration Number: NCT01298115

Locations: 🇦🇺
University of Sydney, Sydney, New South Wales, Australia

Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Phase 2

Completed

Conditions: Macular Edema
Diabetic Retinopathy

Interventions: Drug: bevacizumab
Drug: dexamethasone

First Posted Date: 2011-02-17

Last Posted Date: 2015-06-03

Lead Sponsor: University of Sydney

Target Recruit Count: 61

Registration Number: NCT01298076

Locations: 🇦🇺
Save Sight Institute, Sydney, New South Wales, Australia
🇦🇺
South West Retina, Sydney, New South Wales, Australia
🇦🇺
Lions Eye Institute, Perth, Western Australia, Australia

and more 1 locations

Appropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysis

Not Applicable

Completed

Conditions: Infant, Newborn, Diseases
Infant, Premature, Diseases
Bronchopulmonary Dysplasia
Retinopathy of Prematurity
Infant, Very Low Birth Weight

Interventions: Procedure: Higher oxygen saturation target range (91%-95%)
Procedure: Lower oxygen saturation (85%-89%)

First Posted Date: 2010-05-17

Last Posted Date: 2019-03-13

Lead Sponsor: University of Sydney

Target Recruit Count: 4965

Registration Number: NCT01124331

Locations: 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital Women and Babies, Camperdown, New South Wales, Australia
🇦🇺
John Hunter Hospital, New Lambton, New South Wales, Australia

and more 6 locations

Korean Diet Efficacy Clinical Trial

Not Applicable

Conditions: Obesity

Interventions: Behavioral: Provision of 2 Korean meals per day 6 days per week
Behavioral: Western Diet

First Posted Date: 2010-05-14

Last Posted Date: 2010-05-14

Lead Sponsor: University of Sydney

Target Recruit Count: 70

Registration Number: NCT01124071

Locations: 🇦🇺
The University of Sydney, Sydney, New South Wales, Australia

Attention Training and Its Effects on Body Image Disturbance

Not Applicable

Completed

Conditions: Body Dissatisfaction
Eating Disorder Symptoms

Interventions: Behavioral: placebo training
Behavioral: attention training

First Posted Date: 2010-04-26

Last Posted Date: 2010-04-26

Lead Sponsor: University of Sydney

Target Recruit Count: 32

Registration Number: NCT01110265

Locations: 🇦🇺
The University of Sydney, Sydney, New South Wales, Australia

Attention Training and Cognitive Therapy

Not Applicable

Completed

Conditions: Social Phobia

Interventions: Behavioral: attention training
Behavioral: Cognitive therapy

First Posted Date: 2010-03-25

Last Posted Date: 2010-03-25

Lead Sponsor: University of Sydney

Target Recruit Count: 46

Registration Number: NCT01093313

Locations: 🇦🇺
The University of Sydney, Sydney, New South Wales, Australia

Osteonecrosis of the Hip and Bisphosphonate Treatment

Phase 2

Conditions: Osteonecrosis

Interventions: Drug: Placebo
Drug: Zoledronic Acid

First Posted Date: 2008-10-28

Last Posted Date: 2013-01-14

Lead Sponsor: University of Sydney

Target Recruit Count: 120

Registration Number: NCT00781261

Locations: 🇦🇺
Royal North Shore Hospital, Department of Rheumatology, Sydney, New South Wales, Australia
🇦🇺
The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy